Open Access Green as soon as Postprint is submitted to ZB.
Adipocyte p62/SQSTM1 suppresses tumorigenesis through opposite regulations of metabolism in adipose tissue and tumor.
Cancer Cell 33, 770-784.e6 (2018)
Obesity is a leading risk factor for cancer. However, understanding the crosstalk between adipocytes and tumor cells in vivo, independently of dietary contributions, is a major gap in the field. Here we used a prostate cancer (PCa) mouse model in which the signaling adaptor p62/Sqstm1 is selectively inactivated in adipocytes. p62 loss in adipocytes results in increased osteopontin secretion, which mediates tumor fatty acid oxidation and invasion, leading to aggressive metastatic PCa in vivo. Furthermore, p62 deficiency triggers in adipocytes a general shutdown of energy-utilizing pathways through mTORC1 inhibition, which supports nutrient availability for cancer cells. This reveals a central role of adipocyte's p62 in the symbiotic adipose tissue-tumor collaboration that enables cancer metabolic fitness.
Impact Factor
Scopus SNIP
Scopus
Cited By
Cited By
Altmetric
22.844
4.742
59
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Cpt1 ; Adipocyte ; Cancer ; Fatty Acid Oxidation ; Metabolic Reprogramming ; Obesity ; Osteopontin ; P62 ; Prostate ; Sequestosome-1
Language
Publication Year
2018
HGF-reported in Year
2018
ISSN (print) / ISBN
1535-6108
e-ISSN
1878-3686
Journal
Cancer Cell
Quellenangaben
Volume: 33,
Issue: 4,
Pages: 770-784.e6
Publisher
Cell Press
Publishing Place
Cambridge, Mass.
Reviewing status
Peer reviewed
Institute(s)
Institute of Diabetes and Obesity (IDO)
POF-Topic(s)
30201 - Metabolic Health
90000 - German Center for Diabetes Research
90000 - German Center for Diabetes Research
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502200-001
G-501900-221
G-501900-221
Scopus ID
85044003596
PubMed ID
29634950
Erfassungsdatum
2018-05-25